Gaelle Nachbaur
23, Rue François Jacob
Rueil-malmaison, 92500, France
Rueil-malmaison, 92500, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Real-world outcomes and management of endometrial cancer in France from 2016 to 2021 (MOONBEAM study).
Journal: Bulletin du cancer
Published: January 19, 2026
Use of fluticasone/umeclidinium/vilanterol in France: A population based study
Journal: Revue des maladies respiratoires
Published: March 22, 2024
Public Health Impact and Cost-Effectiveness Analysis of 4-Component Meningococcal Serotype B Vaccination for Infants in France.
Journal: PharmacoEconomics - open
Published: March 20, 2024
Care pathways in invasive meningococcal disease: a retrospective analysis of the French national public health insurance database.
Journal: Human vaccines & immunotherapeutics
Published: February 22, 2022
Costs and mortality associated with HIV: a machine learning analysis of the French national health insurance database.
Journal: Journal of public health research
Published: September 01, 2021
Healthcare Resource Consumption and Cost of Invasive Meningococcal Disease in France: A Study of the National Health Insurance Database.
Journal: Infectious diseases and therapy
Published: February 17, 2021
Dose-related and contextual aspects of suboptimal adherence to antiretroviral therapy among persons living with HIV in Western Europe.
Journal: European journal of public health
Published: January 19, 2021
Risk factors for invasive meningococcal disease: a retrospective analysis of the French national public health insurance database.
Journal: Human vaccines & immunotherapeutics
Published: January 15, 2021
Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC).
Journal: Drug safety
Published: September 12, 2020
Benefit-Risk Assessment of Vaccines. Part I: A Systematic Review to Identify and Describe Studies About Quantitative Benefit-Risk Models Applied to Vaccines.
Journal: Drug safety
Published: September 11, 2020
Factors associated with interest in a long-acting HIV regimen: perspectives of people living with HIV and healthcare providers in four European countries.
Journal: Sexually transmitted infections
Published: June 12, 2020
Last Updated: 09/26/2026